跳至主要内容
临床试验/IRCT20200710048068N1
IRCT20200710048068N1招募中3 期

Efficacy of melatonin for the treatment of moderate to severe vincristine-induced neuropathy in pediatric malignancies

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 12 years(—)
性别
All

入选标准

  • Age: 6-12 years old
  • Patients with ALL
  • Incidence of neuropathy following receiving vincristine

排除标准

  • Hypersensitivity to melatonin
  • Patients over 12 years of age
  • CNS tumor (except meduloblastoma), focal neurological symptoms, CN metastasis
  • Other neuromuscular disorders (traumatic brain injury, cerebral palsy)
  • Recurrent diseases
  • Unstable hemodynamic status
  • Amputation of upper and lower limbs

研究者

相似试验